Does MACITENTAN Cause Stent placement? 108 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 108 reports of Stent placement have been filed in association with MACITENTAN (OPSYNVI). This represents 0.2% of all adverse event reports for MACITENTAN.
108
Reports of Stent placement with MACITENTAN
0.2%
of all MACITENTAN reports
13
Deaths
89
Hospitalizations
How Dangerous Is Stent placement From MACITENTAN?
Of the 108 reports, 13 (12.0%) resulted in death, 89 (82.4%) required hospitalization, and 9 (8.3%) were considered life-threatening.
Is Stent placement Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MACITENTAN. However, 108 reports have been filed with the FAERS database.
What Other Side Effects Does MACITENTAN Cause?
Dyspnoea (8,315)
Death (5,864)
Headache (4,856)
Diarrhoea (3,669)
Pneumonia (3,531)
Nausea (3,463)
Hospitalisation (3,414)
Fatigue (3,172)
Fluid retention (2,861)
Dizziness (2,704)
What Other Drugs Cause Stent placement?
RANOLAZINE (593)
EVOLOCUMAB (244)
ADALIMUMAB (227)
ROSIGLITAZONE (196)
ETANERCEPT (174)
CLOPIDOGREL BISULFATE (167)
RIVAROXABAN (122)
ASPIRIN (118)
APIXABAN (116)
FLUTICASONE\SALMETEROL (105)
Which MACITENTAN Alternatives Have Lower Stent placement Risk?
MACITENTAN vs MACITENTAN\TADALAFIL
MACITENTAN vs MAGNESIUM
MACITENTAN vs MAGNESIUM ASPARTATE
MACITENTAN vs MAGNESIUM ASPARTATE\POTASSIUM ASPARTATE
MACITENTAN vs MAGNESIUM HYDROXIDE